Transvaginal mesh devices are surgically implanted in women to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI). The devices are designed to prevent internal organs from coming into contact with each other, but have resulted in numerous complications for patients, including:
- Mesh erosion into the vagina, bladder, intestines, and uterus
- Serious infection
- Pelvic pain
- Urinary problems
- Development of urinary retention
- Bowel, bladder, and blood vessel perforation during insertion
- Vaginal scarring
- Pain with sexual relations
- Recurrence of prolapsed organs and/or incontinence
- Neuropathic pain
Some women have required revision surgery, blood transfusions, IV therapy, and the drainage of hematomas or abscesses to correct the damage allegedly caused by transvaginal mesh devices.
FDA Warnings Regarding Transvaginal Mesh Devices
In 2011, the FDA warned that the use of surgical mesh to treat pelvic organ prolapse may have greater risk than other surgeries without evidence of greater benefit, and in 2014, the FDA proposed a reclassification of surgical mesh devices used for POP from being a moderate-risk device to a high-risk device. This came after a September 2011 advisory panel recommended that the devices be reclassified. The U. S. Food and Drug Administration (FDA) has released repeated warnings about transvaginal mesh devices, but the products have yet to be recalled.
While some manufacturers have taken steps to settle some of the mesh implant lawsuits pending against them, others have not and continue to blame patients, doctors and other unrelated factors.
If you have suffered complications due to the implantation of a transvaginal patch to treat POP or SUI, you are not alone, and may have a right to compensation. By filing a claim against the surgical mesh manufacturer, you could receive compensation for medical costs, lost wages, other financial burdens and for the pain and suffering caused by this defective medical device.
*Please note on the manufacturers that are trying to do the right thing and have started to settle certain products we are no longer taking those type of implants or manufacturer cases. For the other manufacturers that refuse to materially discuss resolving and compensating those affected by their products, we continue to review ongoing claims as needed.
A partner with Childers, Schlueter & Smith, LLC,, Brandon Smith has devoted his practice to pharmaceutical litigation, mass torts, products liability and serious personal injury. A frequent guest speaker at legal seminars all over the country—Brandon is focused on helping injured victims nationwide, however possible. Named a SuperLawyer again in 2019, he has also been called out as one of 10 Best Attorneys For Georgia by the American Institute Of Personal Injury Attorneys and a Top 100 Lawyer in Georgia by the National Trial Lawyers in 2019.
Comments for this article are closed.